Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

FBXO43 antibody (C-Term)

This anti-FBXO43 antibody is a Rabbit Polyclonal antibody detecting FBXO43 in WB. Suitable for Human.
Catalog No. ABIN1881339

Quick Overview for FBXO43 antibody (C-Term) (ABIN1881339)

Target

See all FBXO43 Antibodies
FBXO43 (F-Box Protein 43 (FBXO43))

Reactivity

  • 7
  • 3
  • 1
  • 1
Human

Host

  • 6
  • 2
  • 1
Rabbit

Clonality

  • 7
  • 2
Polyclonal

Conjugate

  • 9
This FBXO43 antibody is un-conjugated

Application

  • 9
  • 4
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB)

Clone

RB42859
  • Binding Specificity

    • 3
    • 1
    • 1
    • 1
    • 1
    AA 668-694, C-Term

    Purification

    This antibody is purified through a protein A column, followed by peptide affinity purification.

    Immunogen

    This FBXO43 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 668-694 amino acids from the C-terminal region of human FBXO43.

    Isotype

    Ig Fraction
  • Application Notes

    WB: 1:1000

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C,-20 °C

    Expiry Date

    6 months
  • Target

    FBXO43 (F-Box Protein 43 (FBXO43))

    Alternative Name

    FBXO43

    Background

    Required to establish and maintain the arrest of oocytes at the second meiotic metaphase until fertilization. Probably acts by inhibiting the anaphase-promoting complex/cyclosome (APC/C) ubiquitin ligase. Probably recognizes and binds to some phosphorylated proteins and promotes their ubiquitination and degradation (Probable).

    Molecular Weight

    78402

    NCBI Accession

    NP_001025031

    UniProt

    Q4G163
You are here:
Chat with us!